Clinical and endoscopic analysis of gastrointestinal bleeding during COVID-19 full-blown pandemic: a retrospective cohort study

Although endoscopy is a commonly used technique in patients with gastrointestinal bleeding (GIB), there is currently insufficient evidence to inform clinicians on how to manage patients with gastrointestinal bleeding during COVID-19 full-blown pandemic. Herein, we analyzed the clinical and endoscopic characteristics of GIB in patients hospitalized during COVID-19 full-blown pandemic. Patients with GIB during the initial stage of COVID-19 pandemic and COVID-19 full-blown pandemic were enrolled and defined as Group 1 and Group 2, respectively. Comeparing the differences in the 30 days mortality, the need for intensive care unit (ICU) level of care, laboratory examination, blood transfusion and anticoagulant therapy, use of non-steroidal anti-inflammatory drugs (NSAIDs), frequency of endoscopy, and examination results between the two groups. Compared to GIB patients in initial stage of COVID-19 pandemic, prothrombin time (PT) (15.45 s vs 13.84 s, <i>p</i> = 0.003), activated partial prothrombin time (APTT) (33.13 s vs 27.28 s, <i>p</i> = 0.001), d-dimer (mg/L) (730.44 vs 507.22, <i>p</i> = 0.041), and prothrombin activity (PTA) (75.79% vs 76.61%, <i>p</i> = 0.001) were higher in GIB patients during COVID-19 pandemic. Furthermore, an increased need for ICU stays (%) (16.9% vs 3.8%, <i>p</i> = 0.020) and anticoagulant therapy (%) (38.2% vs 5.7%, <i>p</i> &lt; 0.001), higher use of NSAIDs (%) (25.8% vs 3.8%, <i>p</i> = 0.001) and lower frequency of endoscopy (%) (41.6% vs 73.6%, <i>p</i> &lt; 0.001) were seen during COVID-19 full-blown pandemic. During COVID-19 full-blown pandemic, the number of patients with GIB increased significantly; these patients were more likely to require ICU admission. Although the endoscopic intervention rate was significantly reduced in COVID-19 patients, there were no significant differences in hospital stay, blood transfusion requirements, rebleeding rate, and mortality.

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29582151
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical and endoscopic analysis of gastrointestinal bleeding during COVID-19 full-blown pandemic: a retrospective cohort study

Figshare
Gastrointestinal Bleeding Diagnosis and Treatment
article

Clinical and endoscopic analysis of gastrointestinal bleeding during COVID-19 full-blown pandemic: a retrospective cohort study

article en

Abstract

Although endoscopy is a commonly used technique in patients with gastrointestinal bleeding (GIB), there is currently insufficient evidence to inform clinicians on how to manage patients with gastrointestinal bleeding during COVID-19 full-blown pandemic. Herein, we analyzed the clinical and endoscopic characteristics of GIB in patients hospitalized during COVID-19 full-blown pandemic. Patients with GIB during the initial stage of COVID-19 pandemic and COVID-19 full-blown pandemic were enrolled and defined as Group 1 and Group 2, respectively. Comeparing the differences in the 30 days mortality, the need for intensive care unit (ICU) level of care, laboratory examination, blood transfusion and anticoagulant therapy, use of non-steroidal anti-inflammatory drugs (NSAIDs), frequency of endoscopy, and examination results between the two groups. Compared to GIB patients in initial stage of COVID-19 pandemic, prothrombin time (PT) (15.45 s vs 13.84 s, <i>p</i> = 0.003), activated partial prothrombin time (APTT) (33.13 s vs 27.28 s, <i>p</i> = 0.001), d-dimer (mg/L) (730.44 vs 507.22, <i>p</i> = 0.041), and prothrombin activity (PTA) (75.79% vs 76.61%, <i>p</i> = 0.001) were higher in GIB patients during COVID-19 pandemic. Furthermore, an increased need for ICU stays (%) (16.9% vs 3.8%, <i>p</i> = 0.020) and anticoagulant therapy (%) (38.2% vs 5.7%, <i>p</i> &lt; 0.001), higher use of NSAIDs (%) (25.8% vs 3.8%, <i>p</i> = 0.001) and lower frequency of endoscopy (%) (41.6% vs 73.6%, <i>p</i> &lt; 0.001) were seen during COVID-19 full-blown pandemic. During COVID-19 full-blown pandemic, the number of patients with GIB increased significantly; these patients were more likely to require ICU admission. Although the endoscopic intervention rate was significantly reduced in COVID-19 patients, there were no significant differences in hospital stay, blood transfusion requirements, rebleeding rate, and mortality.

Figshare
Good health and well-being
Openalex Percentile: Top 38%
Gastrointestinal Bleeding Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical and endoscopic analysis of gastrointestinal bleeding during COVID-19 full-blown pandemic: a retrospective cohort study · Figshare (2025) | TGRS Research Map | TGRS